- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06297824
Feasibility of Emotion Regulation Group Therapy for Adolescent Self-Harm (ERGT-A)
Can a Brief Emotion Regulation Group Therapy Help Adolescents With Deliberate Self-Harm? A Feasibility Study and a Qualitative Interview Study
Deliberate self-harm (DSH) is a prevalent behaviour among adolescents but there is no current recommendation for an efficacious treatment. Emotion regulation group therapy (ERGT) is a brief treatment for DSH with a well-documented utility and feasibility in the adult population, and an adapted version for adolescents may provide equal benefits for adolescents, provided adjustments to prevent or decrease social contagion are present.
A quantitative feasibility open trial (N=20) followed up by a qualitative interview study will examine the feasibility, acceptability and preliminary effect of ERGT for adolescents.
Study Overview
Status
Intervention / Treatment
Detailed Description
Deliberate self-harm (DSH) is a prevalent behaviour among adolescents but there is no current recommendation for an efficacious treatment. Emotion regulation group therapy (ERGT) is a brief treatment for DSH with a well-documented utility and feasibility in the adult population, and an adapted version for adolescents may provide equal benefits for adolescents, provided adjustments to prevent or decrease social contagion are present. Adaptations to ERGT will result in a 12 session long treatment for adolescents Emotion regulation group therapy for Adolescents (ERGT-A). A parallel parent group focused on strengthening parental skills will be given alongside ERGT-A (5 sessions)
Method: A quantitative feasibility open trial (N=20) with pre, post and 1 month follow-up assessments will examine the feasibility, acceptability and preliminary effect of ERGT for adolescents.
Feasibility measures include recruitment rate, proportion beginning treatment, attrition, treatment credibility and satisfaction, negative effects, and alliance.
Preliminary effects measures include DSH, emotion regulation ability, anxiety and depression.
Method: A qualitative interview study. Using thematic analysis to explore participants' experience of ERGT-A and parent group
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Dimitar Krastev, MSc
- Phone Number: +46735269516
- Email: Dimitar.Krastev@prima.se
Study Locations
-
-
Spånga
-
Stockholm, Spånga, Sweden, 16374
- Recruiting
- Prima Barn och Vuxenpsykiatri Handen och Järva
-
Contact:
- Dimitar Krastev, MSc
- Phone Number: +46735269516
- Email: Dimitar.Krastev@prima.se
-
Contact:
- MaiBritt Giacobini, PhD
- Phone Number: +46709736662
- Email: Maibritt.Giacobini@prima.se
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 13-17 years of age;
- having engaged in deliberate self-harm (DSH)-behaviours ≥ 5 times the last year;
- having engaged in ≥1 DSH episode during the past month;
- having ongoing psychiatric treatment in the community;
- having at least one caregiver or other significant adult, committed to participate in the parent program; and
- stability of psychotropic medications
Exclusion Criteria:
- a diagnosis of psychotic, bipolar I disorder or severe social anxiety disorder (SAD);
- ongoing substance dependence;
- the presence of co-occurring psychiatric disorders that require immediate treatment;
- having an autism spectrum disorder together with borderline intellectual disability or having an intellectual disability;
- insufficient understanding of the Swedish language
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: ERGT-A
12 session emotion regulation treatment in group format.
Psychoeducation and homework assignments.
Subjects taught are the function of deliberate self-harm (DSH), functionality of emotions, negative consequences of emotional avoidance, non-avoidant emotion regulation.
|
Emotion regulation group therapy for adolescents
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility measure, recruitment rate
Time Frame: through study completion, an average of 1 year
|
Recruitment rate
|
through study completion, an average of 1 year
|
Feasibility measures, proportion included
Time Frame: through study completion, an average of 1 year
|
Proportion of participants invited to participate who accepts and is included (higher = better, min 0%- max 100%)
|
through study completion, an average of 1 year
|
Feasibility measures, compliance
Time Frame: Pre-treatment to post-treatment (End of treatment, EOT) (12 weeks)
|
Compliance, no of sessions attended (>50%), (higher = better, min 0-max 10)
|
Pre-treatment to post-treatment (End of treatment, EOT) (12 weeks)
|
Feasibility measures, attrition
Time Frame: Pre-treatment to post-treatment EOT (12 weeks)
|
Attrition, percent of included participants who drops out of treatment (lower = better, min 0%- max 100%)
|
Pre-treatment to post-treatment EOT (12 weeks)
|
Feasibility measures, client satisfaction
Time Frame: at post-treatment EOT (12 weeks)
|
Mean score on Client satisfaction questionnaire> 25 (higher= better, min 8-max 32)
|
at post-treatment EOT (12 weeks)
|
Feasibility measures, negative effects of treatment
Time Frame: at post-treatment EOT (12 weeks)
|
Low rating on Negative effects Questionnaire (lower= better, min 0-max 20)
|
at post-treatment EOT (12 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Preliminary effect, self harm frequency EOT
Time Frame: Pre-treatment to post-treatment (EOT) (12 weeks)
|
Mean Deliberate self-harm frequency at post-treatment (min 0-max 100, lower=better)
|
Pre-treatment to post-treatment (EOT) (12 weeks)
|
Preliminary effect, self harm frequency 1MFU
Time Frame: Post-treatment (EOT) to follow-up (4 weeks)
|
Mean Deliberate self-harm frequency at post-treatment and 1MFU lower than at post-treatment (min 0-max 100, lower=better)
|
Post-treatment (EOT) to follow-up (4 weeks)
|
Preliminary effect, emotion dysregulation EOT
Time Frame: Pre-treatment to post-treatment (EOT) (12 weeks)
|
Mean difficulty in emotion regulation rating (DERS-16) at post-treatment lower than at pre-treatment (min 16, max 80, lower=better)
|
Pre-treatment to post-treatment (EOT) (12 weeks)
|
Preliminary effect, emotion dysregulation 1MFU
Time Frame: Post-treatment (EOT) to follow-up (4 weeks)
|
Mean difficulty in emotion regulation rating (DERS-16) at 1MFU lower than at post-treatment (min 16, max 80, lower=better)
|
Post-treatment (EOT) to follow-up (4 weeks)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hanna Sahlin, PhD, Karolinska Institutet
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-04909-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Emotion Regulation
-
University of ValenciaMinisterio de Ciencia e Innovación, SpainRecruitingIntervention on Socio-emotional Development and Well-being Through ICTs in Early Adulthood (EMOWELL)Emotion RegulationSpain
-
VU University of AmsterdamUtrecht UniversityRecruiting
-
Douglas Mental Health University InstituteMcGill University; MedTeq; Natural Sciences and Engineering Research Council,... and other collaboratorsRecruiting
-
Miami UniversityUniversity of California, RiversideWithdrawn
-
University Grenoble AlpsActive, not recruiting
-
University of CyprusUniversity of Crete; VU University of Amsterdam; Eotvos Lorand UniversityRecruiting
-
Virginia Commonwealth UniversityMind and Life Institute, Hadley, MassachusettsRecruitingEmotion RegulationUnited States
-
Babes-Bolyai UniversityThe Executive Agency for Higher Education, Research, Development and Innovation...CompletedEmotion RegulationRomania
-
Maltepe UniversityCompletedStress | Emotion RegulationTurkey
-
University of MiamiThe Children's Trust, Miami FLRecruiting
Clinical Trials on ERGT-A
-
Karolinska InstitutetCompletedBorderline Personality Disorder | Non-suicidal Self-injury (NSSI)Sweden
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedCorneal Infiltrative Events | Corneal InflammationUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Coopervision, Inc.Completed
-
Bausch & Lomb IncorporatedCompleted
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.University of ManchesterCompleted